Among the flagship measures tabled in Bill 67 is the power granted to pharmacists to do more tests and to prescribe and renew prescriptions indefinitely.
Some studies have demonstrated lower mortality with phosphodiesterase-5 inhibitor treatment for erectile dysfunction in men with stable coronary artery disease, compared with no treatment.